Skip to main content
. 2018 May 11;32(6):567–578. doi: 10.1007/s40263-018-0522-8

Table 4.

Dosage forms of medications taken by the 291 patients for acute treatment and comparison between chronic and episodic headache patients (some patients took more than one symptomatic drug of more than one dosage form)

Dosage form Total (n = 291), n (%) Episodic headache (n = 172), n (%) Chronic headache (n = 119), n (%) OR [95% CI]a P valueb
Oral 274/291 (94.2) 161/172 (93.6) 113/119 (95.0) 1.29 [0.46–3.59] 0.6290
Intramuscolar 59/291 (20.3) 31/172 (18.0) 28/119 (23.5) 1.40 [0.79–2.49] 0.2515
Subcutaneous 31/291 (10.7) 13/172 (7.6) 18/119 (15.1) 2.18 [1.02–4.67] 0.0400
Rectal 26/291 (8.9) 12/172 (7.0) 14/119 (11.8) 1.78 [0.79–4.01] 0.1599
Nasal spray 6/291 (2.1) 3/172 (1.7) 3/119 (2.5) 1.46 [0.29–7.37] 0.6472

CI confidence interval, OR odds ratio

achronic vs episodic headache OR

bp value is derived from a Chi square test for homogeneity of odds